These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 17064973

  • 1. Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.
    Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, Pischon N, Trackman PC, Gerstenfeld L, Graves DT.
    Bone; 2007 Feb; 40(2):345-53. PubMed ID: 17064973
    [Abstract] [Full Text] [Related]

  • 2. Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor.
    Alikhani M, Maclellan CM, Raptis M, Vora S, Trackman PC, Graves DT.
    Am J Physiol Cell Physiol; 2007 Feb; 292(2):C850-6. PubMed ID: 17005604
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways.
    Chen YS, Wang XJ, Feng W, Hua KQ.
    Int J Mol Med; 2017 Oct; 40(4):987-998. PubMed ID: 28849117
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z, Jiang Y, Liu N, Ren L, Zhu Y, An Y, Chen D.
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. iRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth muscle cells.
    Maltais JS, Simard E, Froehlich U, Denault JB, Gendron L, Grandbois M.
    Pharmacol Res; 2016 Feb; 104():176-85. PubMed ID: 26707030
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-κB.
    Zhang HB, Zhang Y, Chen C, Li YQ, Ma C, Wang ZJ.
    Apoptosis; 2016 Oct; 21(10):1082-93. PubMed ID: 27515513
    [Abstract] [Full Text] [Related]

  • 17. Advanced glycation end products induced IL-6 and VEGF-A production and apoptosis in osteocyte-like MLO-Y4 cells by activating RAGE and ERK1/2, P38 and STAT3 signalling pathways.
    Chen H, Liu W, Wu X, Gou M, Shen J, Wang H.
    Int Immunopharmacol; 2017 Nov; 52():143-149. PubMed ID: 28910744
    [Abstract] [Full Text] [Related]

  • 18. Advanced glycation end-products increase IL-6 and ICAM-1 expression via RAGE, MAPK and NF-κB pathways in human gingival fibroblasts.
    Nonaka K, Kajiura Y, Bando M, Sakamoto E, Inagaki Y, Lew JH, Naruishi K, Ikuta T, Yoshida K, Kobayashi T, Yoshie H, Nagata T, Kido J.
    J Periodontal Res; 2018 Jun; 53(3):334-344. PubMed ID: 29193068
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.